ro.co glp 1 reviews

Last updated: September 25, 2026
Quick Answer: Ro.co (also written as ro.co) is a telehealth platform that connects adults with licensed providers who can prescribe GLP-1 medications, including semaglutide, for weight loss. Based on available ro.co glp 1 reviews, most users report meaningful appetite suppression and gradual weight loss, though results vary, costs can be significant, and the experience depends heavily on which medication and formulation you receive. It is a legitimate medical service, not a supplement brand.
Key Takeaways
- Ro.co is a telehealth company, not a supplement manufacturer. It prescribes FDA-approved and compounded GLP-1 medications through licensed providers.
- Most verified user reviews report 5-15% body weight loss over 3-6 months when combined with diet changes, though individual results vary widely.
- Common side effects include nausea, constipation, and fatigue, especially during the dose escalation phase.
- Pricing is a frequent complaint in ro.co glp 1 reviews. Monthly costs can range from roughly $99 to over $400 depending on the medication and formulation.
- Ro.co has offered compounded semaglutide, which is cheaper than brand-name Ozempic or Wegovy but carries different regulatory considerations.
- Customer service responsiveness is a mixed point in reviews. Many users praise the convenience; others cite slow provider response times.
- GLP-1 medications require a prescription and are not appropriate for everyone. A medical evaluation is required before starting.
- Ro.co competes with services like Hims, Henry Meds, and Medvi. Each has different pricing structures and medication options.
What Is Ro.co GLP-1 and How Does It Work
Ro.co is a direct-to-consumer telehealth platform that offers access to GLP-1 receptor agonist medications for weight management. The platform connects patients with licensed healthcare providers who evaluate eligibility, write prescriptions, and oversee ongoing treatment, all done remotely.
GLP-1 (glucagon-like peptide-1) is a hormone your gut naturally releases after eating. GLP-1 receptor agonists mimic this hormone by binding to GLP-1 receptors in the brain, pancreas, and gastrointestinal tract. The result is a combination of effects that support weight loss:
- Appetite suppression: The hypothalamus receives signals that reduce hunger and food cravings.
- Slowed gastric emptying: Food moves more slowly through the stomach, so you feel full longer.
- Improved insulin response: The pancreas releases insulin more efficiently in response to meals, which also supports blood sugar regulation.
- Reduced caloric intake: Because hunger is blunted, most users naturally eat less without intense willpower effort.
Ro.co primarily offers semaglutide, the active ingredient in Ozempic and Wegovy. Depending on availability and your clinical profile, the platform may prescribe brand-name or compounded versions.

For a broader look at how semaglutide performs across different platforms and patient experiences, see these compounded semaglutide reviews with real patient stories.
Ro.co GLP-1 Reviews Reddit: What Real Users Are Saying
Reddit is one of the most candid sources for ro.co glp 1 reviews, and the feedback is genuinely mixed, which is actually a good sign for credibility.
Positive themes across Reddit threads (r/Semaglutide, r/WeightLoss, r/Ozempic):
- Users frequently mention that the onboarding process is fast and straightforward, with prescriptions issued within 24-72 hours of submitting intake forms.
- Many report losing 10-20 pounds within the first 8-12 weeks, especially when following dietary guidance.
- Several users specifically praise the affordability of Ro.co’s compounded semaglutide compared to brand-name alternatives.
Negative themes:
- A recurring complaint is that provider communication can be slow after the initial prescription. Some users report waiting several days for responses to questions about side effects.
- A number of posts mention confusion around dose escalation schedules, particularly when transitioning from lower to higher doses.
- Some users were disappointed when Ro.co shifted its medication offerings due to FDA compounding policy changes in 2024-2025, which affected availability and pricing.
Bottom line from Reddit: Ro.co appears to work for many users who stay consistent and have realistic expectations. The platform’s value proposition is convenience and lower cost, not white-glove medical care.
Is Ro.co GLP-1 Safe and Effective
For most medically appropriate adults, ro.co’s GLP-1 prescriptions are both safe and effective when used under provider supervision. GLP-1 receptor agonists have a well-established clinical evidence base.
Evidence level: Strong for semaglutide specifically.
The STEP clinical trial program, published in the New England Journal of Medicine (Wilding et al., 2021), found that adults using semaglutide 2.4 mg weekly lost an average of 14.9% of body weight over 68 weeks compared to 2.4% in the placebo group. This is the same active ingredient Ro.co prescribes.
Safety considerations:
- GLP-1 medications are not appropriate for people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
- They are not recommended during pregnancy or breastfeeding.
- People with a history of pancreatitis should discuss risks with a physician before starting.
- Ro.co requires a medical intake form and provider review before prescribing, which adds a layer of clinical screening.
The platform itself does not manufacture medications. It connects you with licensed providers and, in many cases, a partner pharmacy. The safety of the medication is therefore tied to the quality of the pharmacy dispensing it, which matters more when compounded formulations are involved.
Ro.co GLP-1 Cost and Pricing
Pricing is one of the most searched aspects of ro.co glp 1 reviews, and for good reason. Costs vary depending on the medication type, dose, and any ongoing subscription structure.
General pricing ranges (as of 2026, subject to change):
- Compounded semaglutide through Ro.co has historically been priced in the range of $99,$299 per month depending on dose.
- Brand-name options (where available) are significantly more expensive and depend on insurance coverage.
- Ro.co charges a separate membership or program fee in some cases, which adds to the total monthly cost.
What affects your cost:
- Whether you qualify for insurance coverage (most GLP-1 medications for weight loss are not covered by standard plans)
- The dose you require (higher doses cost more)
- Whether you receive compounded or brand-name semaglutide
- Any promotional pricing for new members
For a broader comparison of where to find the most affordable semaglutide options, the cheapest pharmacy for semaglutide rankings and reviews is a useful reference.
Common mistake: Many users sign up expecting the lowest advertised price and are surprised when their actual dose costs more. Always confirm the full monthly cost for your specific prescription before committing.
Ro.co GLP-1 vs Other GLP-1 Services: Full Comparison
Ro.co competes directly with several telehealth platforms offering GLP-1 prescriptions. Here is how it stacks up based on available information and user reviews.

| Feature | Ro.co | Hims/Hers | Henry Meds | Medvi |
|---|---|---|---|---|
| Medication offered | Semaglutide (compounded/brand) | Compounded semaglutide | Compounded semaglutide | Semaglutide, tirzepatide |
| Prescription process | Async online intake | Async online intake | Async online intake | Async + video options |
| Provider support | Messaging-based | Messaging-based | Messaging-based | Messaging + video |
| Brand recognition | High | High | Moderate | Moderate |
| Best for | Convenience seekers | Brand-loyal users | Budget-focused users | Users wanting more options |
Choose Ro.co if you want a well-known platform with a streamlined digital experience and are comfortable with asynchronous provider communication.
Consider alternatives if you want video consultations, tirzepatide options, or more hands-on clinical support. For example, the Hims semaglutide review and Henry Meds semaglutide review offer useful comparisons from a user perspective.
Ro.co GLP-1 Side Effects: What to Expect
GLP-1 medications prescribed through Ro.co carry the same side effect profile as semaglutide prescribed anywhere else. Most side effects are gastrointestinal and tend to be most pronounced during dose escalation.
Common side effects (moderate evidence, frequently reported):
- Nausea (most common, especially in the first 4-8 weeks)
- Constipation or diarrhea
- Fatigue
- Headache
- Reduced appetite (this is also the intended effect)
Less common but notable:
- Vomiting
- Acid reflux or GERD symptoms
- Injection site reactions (for injectable formulations)
Serious risks (rare but require immediate medical attention):
- Pancreatitis (severe abdominal pain)
- Gallbladder disease
- Rapid heart rate
- Allergic reactions
Managing side effects: Most users find that side effects diminish after the first 4-6 weeks. Eating smaller meals, staying hydrated, and avoiding high-fat foods during the early weeks can help. If side effects are severe or persistent, contact your Ro.co provider through the platform’s messaging system.
Does Ro.co GLP-1 Actually Work for Weight Loss
Yes, for most medically appropriate users, GLP-1 medications prescribed through Ro.co do produce meaningful weight loss. The active ingredient, semaglutide, has strong clinical evidence behind it.
Realistic expectations based on clinical data and user reviews:
- Weeks 1-4: Appetite reduction is usually noticeable. Actual weight loss may be modest (1-4 lbs) as the body adjusts.
- Months 2-3: Most users report more consistent weekly losses of 0.5-1.5 lbs per week.
- Months 4-6: Users who stay consistent often report 10-20 lbs of total loss, with some reporting more.
- Beyond 6 months: Weight loss tends to plateau unless the dose is adjusted or lifestyle changes are sustained.
Important caveat: Ro.co’s GLP-1 medications work best when combined with dietary changes and increased physical activity. Users who treat the medication as a standalone solution without any behavioral changes tend to see smaller results.
For perspective on how semaglutide tablets perform compared to injectable versions, the semaglutide tablets reviews page provides additional context.
Ro.co GLP-1: Who Is It For and Who Should Avoid It
Ro.co’s GLP-1 program is designed for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as type 2 diabetes, hypertension, or high cholesterol.
Best suited for:
- Adults with a BMI of 27 or above who have struggled with diet and exercise alone
- People who prefer a fully remote, app-based healthcare experience
- Those without insurance coverage for weight loss medications who want a lower-cost compounded option
- Adults comfortable with self-administering weekly injections
Not ideal for:
- People with a personal or family history of medullary thyroid carcinoma or MEN 2
- Those who are pregnant, planning pregnancy, or breastfeeding
- People with a history of pancreatitis or severe gastrointestinal conditions
- Anyone who needs in-person clinical support or prefers face-to-face consultations
- People on certain medications (consult a pharmacist or physician about interactions)
Ro.co GLP-1 Common Complaints and Customer Service Reviews
Customer service is a recurring theme in ro.co glp 1 reviews, and it is where the platform receives its most consistent criticism.
Top complaints from verified reviews (Trustpilot, Reddit, app store reviews):
- Slow provider response times: Many users report waiting 24-72 hours or longer for replies to clinical questions, which can be frustrating when managing side effects.
- Billing and subscription confusion: Some users report unexpected charges or difficulty canceling subscriptions.
- Medication availability disruptions: The FDA’s 2024-2025 actions on compounded semaglutide affected multiple telehealth platforms including Ro.co, causing supply disruptions and pricing changes that caught some users off guard.
- Dose escalation delays: A few users report that getting dose adjustments approved took longer than expected through the messaging system.
What Ro.co does well according to positive reviews:
- Fast initial onboarding and prescription turnaround
- Clean, user-friendly app interface
- Discreet packaging and reliable shipping
- Responsive chat support for non-clinical billing questions
Edge case to know: If you experience a serious side effect, the asynchronous messaging model is not appropriate. Seek in-person or urgent care immediately and notify Ro.co afterward.
How to Get Started with Ro.co GLP-1: Step-by-Step
Getting started with Ro.co’s GLP-1 program is straightforward. Here is the process as it stands in 2026.

- Complete the online intake form. You will answer questions about your medical history, current medications, weight history, and health goals. This takes about 10-15 minutes.
- Provider medical review. A licensed provider reviews your intake information, typically within 24 hours. They may ask follow-up questions via the messaging system.
- Prescription issued. If you are eligible, the provider issues a prescription. You will be notified through the app.
- Medication shipped. The prescription is sent to a partner pharmacy and shipped directly to your home, usually within 5-7 business days.
- Ongoing check-ins. Ro.co schedules periodic check-ins to review your progress, adjust dosing, and address any concerns.
Prescription requirements: You must be at least 18 years old, meet the BMI criteria, and have no contraindicated conditions. Ro.co does not accept all applicants. If you are denied, the platform should provide a reason through the provider messaging system.
Ro.co GLP-1 vs Compounded GLP-1: Key Differences
Ro.co has offered both brand-name and compounded semaglutide, and understanding the difference matters for both safety and cost decisions.
Brand-name semaglutide (Wegovy, Ozempic):
- FDA-approved for specific indications
- Manufactured under strict pharmaceutical standards
- Significantly more expensive without insurance
- Subject to ongoing shortage issues
Compounded semaglutide:
- Prepared by compounding pharmacies, not FDA-approved as a finished drug product
- Legally available when brand-name versions are on the FDA shortage list (this status has changed over time)
- Generally lower cost
- Quality depends on the compounding pharmacy’s standards and accreditation
Ro.co has used 503B outsourcing facilities for compounded semaglutide, which are subject to FDA oversight and generally considered higher quality than smaller 503A compounding pharmacies. However, the regulatory landscape for compounded GLP-1s shifted significantly in 2024-2025, and users should verify current availability and formulation details directly with Ro.co before enrolling.
For more context on how compounded options compare across providers, the semaglutide reviews covering real results and side effects page is worth reading alongside this one.
Ro.co GLP-1 Results Timeline: What to Realistically Expect
Most users begin noticing appetite changes within the first 1-2 weeks, but visible weight loss results take longer. The timeline below reflects patterns seen across clinical trials and real-world ro.co glp 1 reviews.
| Timeframe | What Most Users Report |
|---|---|
| Week 1-2 | Reduced appetite, possible nausea, minor weight change |
| Week 3-4 | Consistent appetite suppression, 2-5 lbs lost on average |
| Month 2-3 | Steady weekly losses, side effects usually decreasing |
| Month 4-6 | 8-20 lbs total loss common; plateau possible without dose adjustment |
| Month 6+ | Continued loss with dose optimization; maintenance phase begins |
Key variable: Results are strongly tied to diet quality and activity level. The medication reduces hunger, but it does not override a high-calorie diet entirely.
Frequently Asked Questions
Is Ro.co GLP-1 a legitimate medical service?
Yes. Ro.co is a licensed telehealth platform that connects users with licensed healthcare providers who can prescribe FDA-regulated medications. It is not a supplement company or a direct-to-consumer drug seller.
How long does it take to get a prescription from Ro.co?
Most users receive a prescription decision within 24-48 hours of completing the intake form, assuming no additional information is needed.
Can I use insurance with Ro.co for GLP-1 medications?
In most cases, GLP-1 medications prescribed for weight loss are not covered by standard insurance plans. Ro.co primarily serves cash-pay patients, though the situation varies by plan and indication.
What happens if I stop taking GLP-1 medication from Ro.co?
Clinical evidence, including data from the STEP trial extension studies, shows that most people regain a significant portion of lost weight after stopping GLP-1 medications if lifestyle changes are not maintained. This is a known limitation of the drug class, not specific to Ro.co.
Is Ro.co’s compounded semaglutide the same as Ozempic or Wegovy?
The active ingredient is the same (semaglutide), but compounded formulations are not FDA-approved finished drug products. They are prepared by compounding pharmacies and may differ in excipients, concentration, or delivery method.
Does Ro.co offer tirzepatide?
As of 2026, Ro.co’s primary GLP-1 offering has been semaglutide. Tirzepatide availability may vary. Check the platform directly for current options. For tirzepatide-specific user experiences, see tirzepatide reviews by patients.
What is Ro.co’s refund policy?
Ro.co’s refund policy varies by product and situation. Prescription medications are generally non-refundable once dispensed. Membership fees may be refundable within a specific window. Review the terms of service before subscribing.
Is Ro.co GLP-1 safe for people with type 2 diabetes?
GLP-1 medications are actually FDA-approved for type 2 diabetes management (Ozempic). However, if you take insulin or other diabetes medications, there is a risk of hypoglycemia. Discuss this with your prescribing provider before starting.
How does Ro.co compare to Shed GLP-1?
Both are telehealth platforms offering GLP-1 prescriptions. For a direct look at another service in this space, the Shed GLP-1 reviews page provides a useful comparison point.
Can I cancel my Ro.co subscription at any time?
According to user reports, cancellation is possible through the app or by contacting support, but some users report friction in the process. Confirm the cancellation policy before subscribing.
Conclusion: Is Ro.co GLP-1 Worth It?
Based on the available ro.co glp 1 reviews, clinical evidence for semaglutide, and the platform’s track record, here is a clear verdict:
Consider Ro.co if you meet the BMI criteria, want a convenient telehealth path to a GLP-1 prescription, are comfortable with asynchronous provider communication, and understand that results require consistent use alongside dietary changes. The platform is legitimate, the medication has strong clinical backing, and the cost is often lower than brand-name alternatives.
Skip Ro.co if you need hands-on clinical support, prefer video consultations, have contraindications to semaglutide, or are concerned about the regulatory nuances of compounded formulations. In that case, consider a platform that offers video-based care or tirzepatide options.
Actionable next steps:
- Confirm your BMI and check for any contraindications with your primary care provider before starting any GLP-1 program.
- Compare current pricing and medication availability directly on Ro.co’s website, as these change frequently.
- Read independent ro.co glp 1 reviews on Reddit and Trustpilot to get unfiltered user perspectives.
- If cost is your primary concern, compare Ro.co against other platforms using the cheapest pharmacy for semaglutide rankings before deciding.
- Discuss the decision with a healthcare provider, especially if you take medications that may interact with GLP-1 agonists.
GLP-1 medications are among the most effective tools available for weight loss in 2026. Whether Ro.co is the right platform to access them depends on your clinical profile, budget, and preference for how you want to interact with your care team.
References
- Wilding, J. P. H., et al. (2021). “Once-Weekly Semaglutide in Adults with Overweight or Obesity.” New England Journal of Medicine, 384, 989-1002. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
- U.S. Food and Drug Administration. (2021). “FDA Approves New Drug Treatment for Chronic Weight Management.” https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014
- U.S. Food and Drug Administration. (2024). “Compounding and the FDA: Questions and Answers.” https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- Davies, M., et al. (2021). “Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2).” The Lancet, 397(10278), 971-984.
